GRACEcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.

Dr. Lecia Sequist of Massachusetts General Hospital presents a summary of the challenge of acquired resistance to EGFR tyrosine kinase inhibitors like Tarceva (erlotinib) and Iressa (gefitinib), along with emerging ideas for overcoming it.

Direct download: GRACEcast-068_Lung-Video_Sequist_on_EGFR_Resistance.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PDT

Dr. Lecia Sequist of Massachusetts General Hospital presents a summary of the challenge of acquired resistance to EGFR tyrosine kinase inhibitors like Tarceva (erlotinib) and Iressa (gefitinib), along with emerging ideas for overcoming it.

Direct download: GRACEcast-068_Lung-Audio_Sequist_on_EGFR_Resistance.mp3
Category:Lung-Cancer-Audio -- posted at: 8:00am PDT